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Abstract
Background: A strong association between obesity and non-alcoholic fatty liver disease (NAFLD) has been reported.
Objectives: This study was conducted to evaluate if new obesity indices, including a body shape index (ABSI) and body roundness
index (BRI), have stronger associations with NAFLD than waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR).
Methods: In this cross-sectional study, we utilized the data of 4,872 participants aged 18 - 74 years from a cohort study conducted
among 6,143 subjects in northern Iran. Logistic regression analysis was performed on NAFLD as the outcome and obesity measures
(based on Z-score values) as potential predictors. Receiver operating characteristic (ROC) analyses were conducted, in which NAFLD
was considered as a reference variable and obesity measures as classification variables. The discriminatory ability of the obesity
measures was reported based on area-under-the-curves, and the related cut-off points of BRI and WHtR were determined using the
Youden index (YI).
Results: Based on our results, BRI (OR = 5.484 for men and OR = 3.482 for women) and WHtR (OR = 5.309 for men and OR = 3.854 for
women) showed a higher association with NAFLD than ABSI (OR = 1.363 for men and OR = 1.003 for women) and WHR (OR = 3.123 for
men and OR = 1.628 for women). The optimal cut-off points for BRI were 4.00 (sensitivity = 82.7%, specificity = 70.8%) for men and
5.00 (sensitivity = 83.3%, specificity = 71.7%) for women. The optimal cut-off points for WHtR were 0.533 (sensitivity = 82.7%, specificity
= 70.8%) for men and 0.580 (sensitivity = 83.3%, specificity = 71.7%) for women.
Conclusions: While BRI and WHtR have equally strong associations with NAFLD, ABSI and WHR have weaker associations with NAFLD
than BRI and WHtR.
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1. Background
Non-alcoholic fatty liver disease (NAFLD) represents
the leading cause of chronic liver disease in Western coun-
tries (1). One particular study conducted in the United
States estimated that one third of their adult population
suffer from NAFLD (2). Similarly, some studies in European
countries have reported a NAFLD prevalence of 20% - 30%
(3, 4). While the prevalence of non-alcoholic steatohep-
atitis (NASH) was reported as 2% in one study of the gen-
eral Iranian population, the prevalence of NAFLD was esti-
mated to be more than 40% in another study on the same
population (5, 6). Due to rapid urbanization and indus-
trialization, the prevalence of NAFLD has significantly in-
creased in Asian countries; as a result, some studies have
shown a similar prevalence of NAFLD between Asian, Amer-
ican, and European countries in recent years (7). NAFLD can
cause harmful effects to the liver tissue; some studies have
reported that 30% - 70% of cryptogenic cirrhosis cases may
be attributed to NAFLD and NASH (8). Recent data has also
shown that the prevalence of NAFLD-related hepatocellu-
lar carcinoma is increasing (9).
A strong association between obesity and NAFLD has
been reported, and visceral obesity has been suggested to
be the most important predictor for NAFLD (10, 11). Several
new indices of obesity, including a body shape index (ABSI)
and body roundness index (BRI), have recently been intro-
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duced. These indices are calculated based on anthropo-
metric measures including waist circumference, BMI, and
height. Although the predictive ability of obesity indices
has previously been evaluated in terms of their ability to
identify NAFLD, few studies have been conducted to eval-
uate the predictive ability of ABSI and BRI in this context.
In other studies, these indices have been demonstrated as
having some predictive abilities for various areas of health
conditions and diseases such as cardiovascular health sta-
tus, left ventricular hypertrophy, diabetes mellitus, and hy-
peruricemia (12-16).
2. Objectives
This study was conducted to evaluate if ABSI and BRI
can be used to discriminate NAFLD patients, and also to
determine which of the above mentioned indices, includ-
ing ABSI, BRI, WHR, and WHtR, has the stronger association
with NAFLD.
3. Methods
3.1. Study Population
A baseline cohort study was carried out among 6,143
subjects (3,489 men and 2,654 women) aged between 10
and 90 years in Amol, northern Iran. The cohort study was
started in September 2008, and the data collection pro-
cess took 18 months. The sampling frame was provided
from primary healthcare centers, where each citizen had
a health record file. The population of the city was di-
vided into 16 strata according to gender and age groups,
with equivalent intervals of 10 years. The subjects were
randomly selected from each stratum by a proportion to
size approach. Finally, the data of 4,812 subjects (2,769 men
and 2,043 women) aged between 18 and 74 years were an-
alyzed for the purposes of this study. All procedures fol-
lowed were in accordance with the ethical standards of the
committees responsible for human experimentation (in-
stitutional and national) and with the Helsinki declaration
of 1975, as revised in 2008. Informed consent was obtained
from all patients prior to their inclusion in the study, and
was approved by the ethics committee of Iran University of
Medical Sciences. A schematic diagram of the study popu-
lation is shown in Figure 1.
3.2. Data Collection
Trained healthcare providers measured the weight,
height, waist circumference, hip circumference, and blood
pressure of each participant. Weight was measured
when the participants removed excess clothing and shoes.
Height was measured in an upright position, when the
heels and buttocks of the participants were in contact with
the wall. Waist circumference (WC) was determined at the
midpoint of the distance between the lowest costal ridge
and the upper border of the iliac crest. The largest circum-
ference between the waist and the knees was considered
as the hip circumference (HC). Following at least five min-
utes of rest, blood pressure was measured when partici-
pants were in a seated position using a fitted cuff. After
12 hours of fasting, fasting blood sugar (FBS) and lipid pro-
files were obtained and evaluated. All laboratory tests, in-
cluding FBS and lipid profiles, were assessed enzymatically
based on standard protocol using the BS200 Auto Analyzer
(Mindray, China).
Liver ultrasonography was performed on all of the par-
ticipants. NAFLD was defined as evidence of hepatic steato-
sis in ultrasonography, and a lack of evidence for other
causes of acute or chronic hepatitis, such as significant
alcohol consumption, use of steatogenic medication, or
hereditary disorders. All ultrasound examinations were
carried out by an expert radiologist. Homeostasis model
assessment of insulin resistance (HOMA-IR) was calculated
using the following formula:
HOMA− IR = Insulin (mU/mL)×Glucose (mg/dL)
405
(1)
3.3. Statistical Analysis
ABSI, BRI, and WHtR were calculated using the follow-
ing formula:
(2)ABSI =
WC (m)
(BMI [kg/m2])
2
3 × (Height [m]) 12
(3)BRI = 364.2− 365.5
√
1−
(
(WC [m] /2pi)2
(0.5 height [m])2
)
(4)WHtR =
WC (cm)
height (cm)
The univariate and multivariate regression analyses
were performed with NAFLD as the outcome and obesity
measures as the potential predictors. In the multivariate
models, age, triglyceride levels (TG), high density lipopro-
tein levels (HDL), HOMA, and mean arterial pressure (MAP),
in addition to the related obesity measures, were entered
into models as potential mediators. Thus, the association
between obesity measures and NAFLD was evaluated, re-
moving the effects of other variables, in a multivariate
analysis. Regression analyses were performed separately
for men and women. It is worth noting that the Z-scores
of obesity indices were entered into the regression models
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Finally the Data of 4872 Subjects 
Were Analyzed for This Study 
7104 Subjects Aged 10 - 90 Years 
Were Selected to Participate in the 
Cohort Study 
808 Subjects Did Not Agree to 
Participate In the Study 
6296 Subjects Agreed to Participate 
in the Cohort study 153 Pregnant Women Were Excluded 
6143 Subjects Aged 10-90 Years 
Were Included in the Cohort Study 
555 Subjects Aged <18 and ≥ 75 Years  
Were Excluded 
468 Subjects Were Excluded Due to a 
History of Excess Alcohol Consumption, 
a Positive Test of HBs Ag or Anti HCV 
Ab and Regularly Consumption of Drugs 
Associated with Fatty Liver Disease    
5588 Subjects of the Cohort Study 
Were Aged 18-74 Years 
The Data of 248 Subjects Were Not 
Appropriate to Analyze for the Present 
Study Regarding NAFLD 
5120 Subjects Matched the Inclusion 
Criteria of the Present Study  
Figure 1. A Schematic Diagram of the Study Participants and Exclusions
to obtain comparable results for different indices. The Z-
scores were calculated using the following formula:
(5)Z − Score of xi = xi−
−
x
SD
The odds ratios and related confidence intervals along
with P values were recorded. To evaluate the discrimi-
natory ability of the obesity measures, receiver operat-
ing characteristic (ROC) analyses were conducted in which
NAFLD was considered as a reference variable, and obesity
measures as classification variables. To calculate the re-
lated area under the ROC curves (AUCs), the sensitivities of
the infinite decision thresholds of these indices were plot-
ted against their false positive rates. Thus, we were able to
determine the discriminatory ability of these indices in the
diagnosis of NAFLD. The lower boundary line for AUC was
considered as 0.5, since a significantly greater area than
0.5 usually shows the ability of indices to discriminate in-
dividuals with a related condition from individuals with-
out one. The optimal cut-off points of BRI and WHtR in the
discrimination of people with NAFLD from people without
were also determined using maximal values of Youden’s J
statistic as follows:
(6)max {j = Sensitivity + Specificity}
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The values of BRI and ABSI corresponding to a maxi-
mum value of the Youden index were considered as the op-
timal cut-off points for the related indices. The significance
level for all analyses was considered as 0.05. All statistical
analyses were conducted using IBM SPSS Statistics, version
21.0. (Armonk, NY: IBM Corp.) and STATA software, version
12 (STATA Corp., Texas, USA).
4. Results
Table 1 shows the basic characteristics of the study pop-
ulation. Except for HDL, other characteristic values were
significantly higher in individuals with NAFLD than indi-
viduals without NAFLD, with P values < 0.0001.
Table 2 shows the means and related standard devia-
tions for the obesity indices in individuals with and with-
out NAFLD for men and women separately. Based on our
results, the significantly higher values of obesity measures
were related to NAFLD sufferers as compared to others,
with P values < 0.0001.
Table 3 shows the results of univariate and multivari-
ate logistic regression analyses on NAFLD as the outcome
in men and women. Based on our results, BRI (Z-score) and
WHtR (Z-score) showed higher associations with NAFLD
than ABSI and WHR in both analyses for both men and
women.
We evaluated the discriminatory abilities of ABSI, BRI,
WHR, and WHtR in the diagnosis of NAFLD. Their related
AUCs for men were 0.6539 (95% CI = 0.6351 - 0.6727), 0.8457
(95% CI = 0.8320 - 0.8593), 0.8018 (95% CI = 0.7862 - 0.8173),
and 0.8457 (95% CI = 0.8320 - 0.8593), respectively. For
women, the related AUCs were 0.6598 (95% CI = 0.6382 -
0.6814), 0.8566 (95% CI = 0.8419 - 0.8714), 0.7673 (95 %CI =
0.7487 - 0.7860), and 0.8566 (0.8419 - 0.8714), respectively.
The associated graphs are displayed in Figure 2. The op-
timal cut-off points for BRI were 4.00 (sensitivity = 82.7%,
specificity = 70.8%) for men and 5.00 (sensitivity = 83.3%,
specificity = 71.7%) for women. The optimal cut-off points
for WHtR were 0.533 (sensitivity = 82.7%, specificity = 70.8%)
for men and 0.580 (sensitivity = 83.3%, specificity = 71.7%) for
women.
5. Discussion
Our study revealed that ABSI, BRI, WHR, and WHtR were
associated with NAFLD. The association between these in-
dices and NAFLD remained even after removing the effects
of other potential mediators such as age, dyslipidemia,
and insulin resistance. However, BRI and WHtR showed
higher associations with NAFLD than ABSI and WHR. Al-
though BRI is a new index, several studies evaluated its abil-
ity to predict or discriminate the outcomes of heart dis-
eases, hyperuricemia, and diabetes. For example, Chang et
al. reported that BRI is a superior measure than BMI, WC,
and WHtR to determine the presence of left ventricular hy-
pertrophy (LVH), particularly for eccentric LVH (13). Zhang
et al. reported a slightly different ability of BRI, WHtR, and
WC in the diagnosis of hyperuricemia in a cross-sectional
study of a Chinese rural population (16). In an evaluation
of the association between BRI and ABSI and diabetes melli-
tus, Chang et al. determined that neither ABSI nor BRI were
superior to BMI, WC, or WHtR in the discrimination of dia-
betic patients (12). They reported the weakest discrimina-
tory ability for ABSI among the above mentioned indices
(12). Although Maessen et al. reported that BRI was able to
determine the presence of CVD, they did not detect a sig-
nificant difference among BRI, WC, and BMI in this context.
However, WHtR was not evaluated in their study (14).
Our results also revealed an equal discriminatory abil-
ity for BRI and WHtR in the diagnosis of NAFLD. With a
simple and straightforward manipulation of the WHtR for-
mula, we can conclude that BRI is a univariable function of
WHtR using the following formula:
(7)BRI = 364.2− 365.5
√
1−
(
WHtR
pi
)2
As a result, we should not expect a significant differ-
ence between the discriminatory ability of BRI and that of
WHtR. In fact, when we are looking to predict or discrim-
inate a condition such as NAFLD, an equal discriminatory
ability will be obtained from WHtR and BRI. On the other
hand, the optimal cut-off points of BRI and WHtR can be
easily converted to each other using the above equation
(the formula of BRI based on WHtR). In other words, the re-
sults of each of these two indices can be expressed in terms
of the other (more details are discussed in Appendix 1 of the
Supplementary File).
Our calculated cut-off points for BRI (4.00 for men
and 5.00 for women) and WHtR (0.533 in men and 0.58 in
women) were greater for women than for men. The greater
cut-off points of these indices for women compared to
men is not unexpected due to the almost equal WC be-
tween our male and female participants, and a dramati-
cally lower height in our female participants as compared
to the heights of men (regarding the BRI and WHtR for-
mula).
As mentioned above, our results revealed that BRI and
WHtR had high (and equal) discriminatory abilities in the
diagnosis of NAFLD. Although Zheng et al. reported an even
higher discriminatory ability of WHtR than that of our
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Table 1. Basic Characteristics of the Study Participants with and without NAFLD
Characteristics Groupsa P Value
Individuals without NAFLD (n = 2824) Individuals with NAFLD (n = 2048)
Age 39.04± 15.35 48.61± 12.66 < 0.0001
Weight 69.34± 12.64 83.39± 13.93 < 0.0001
WC 84.72± 10.78 99.81± 10.11 < 0.0001
HC 99.82± 8.46 108.53± 9.62 < 0.0001
Height 165.04± 10.07 163.18± 10.20 < 0.0001
WHR 0.8491± 0.0864 0.9213± 0.0726 < 0.0001
WHtR 0.5154± 0.0741 0.6139± 0.0722 < 0.0001
ABSI 0.0766± 0.0058 0.0790± 0.0050 < 0.0001
BRI 3.763± 1.544 5.857± 1.751 < 0.0001
DBP 72.94± 12.07 80.64± 12.45 < 0.0001
SBP 112.07± 14.67 121.77± 16.79 < 0.0001
MAP 85.98± 12.02 94.34± 13.06 < 0.0001
TG 120.38± 74.21 174.89± 115.47 < 0.0001
FBS 94.60± 28.42 108.88± 41.21 < 0.0001
Cholesterol 174.57± 40.74 194.38± 42.77 < 0.0001
HDL 46.96± 11.69 41.45± 11.26 < 0.0001
LDL 101.50± 30.27 114.00± 31.08 < 0.0001
HOMA 1.957± 1.561 3.096± 2.698 < 0.0001
Abbreviations: ABSI, a body shape index; BMI, body mass index; BRI, body roundness index; DBP, diastolic blood pressure; FBS, fasting blood sugar; HC, hip circumference;
HDL-C, high density lipoprotein cholesterol; HOMA, homeostatic model assessment; LDL-C, low density lipoprotein cholesterol; SBP, systolic blood pressure; SD, standard
deviation; TG, triglyceride; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
aValues are presented as mean± SD.
Table 2. The Mean and Standard Deviations of Obesity Measures for Individuals with and without NAFLD for Men and Women Separately
Obesity Indices Groups
Men (n = 2723) Women (n = 2149)
Individuals without
NAFLD (n = 1622)
Individuals with NAFLD
(n = 1101)
P Value Individuals without
NAFLD (n = 1202)
Individuals with NAFLD
(n = 947)
P Value
ABSI 0.0775± 0.0052 0.0797± 0.0043 < 0.0001 0.0754± 0.0064 0.0782± 0.0055 < 0.0001
BRI 3.417± 1.312 5.201± 1.402 < 0.0001 4.233± 1.704 6.618± 1.806 < 0.0001
WHR 0.8670± 0.0853 0.9426± 0.0631 < 0.0001 0.8251± 0.0820 0.8967± 0.0750 < 0.0001
WHtR 0.4984± 0.0657 0.5863± 0.0611 < 0.0001 0.5384± 0.0785 0.6460± 0.0708 < 0.0001
Abbreviations: ABSI, a body shape index; BRI, body roundness index; WHR, waist to hip ratio; WHtR, waist to height ratio; NAFLD, non-alcoholic fatty liver disease.
study, they emphasized that the ability of WHtR was less
than WHR, which is in disagreement with our results (17).
However, the discriminatory ability of BRI was not evalu-
ated in their study. These inconsistent findings among the
studies can be partly attributed to the difference in anthro-
pometric characteristics among various ethnic and racial
groups.
In summary, we evaluated the discriminatory ability of
two new indices of obesity in the diagnosis of NAFLD be-
sides WHR and WHtR in a large community based study.
We also obtained the optimal cut-off points for BRI and
WHtR in the diagnosis of NAFLD in men and women, sepa-
rately. We were able to show that the discriminatory ability
of these two indices is identical, and that the optimal cut-
Hepat Mon. 2016; 16(9):e39575. 5
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Table 3. The Results of Univariate and Multivariate Binary Regression Analyses on NAFLD as the Outcome in Men and Women
Potential Predictors Univariate Multivariate
Wald Od (95% CI) P Value Wald Od (95% CI) P Value
Men (n = 2723)
BRI_Z-score 685.5 7.807 (6.694 - 9.105) < 0.0001 336.6 5.484 (4.572 - 6.577) < 0.0001
ABSI_Z-score 154.5 1.859 (1.686 - 2.050) < 0.0001 25.1 1.363 (1.208 - 1.539) < 0.0001
WC_Z-score 721.1 6.835 (5.940 - 7.864) < 0.0001 293.5 4.881 (4.173 - 5.709) < 0.0001
BMI_Z-score 697.1 7.682 (6.603 - 8.937) < 0.0001 391.5 5.554 (4.686 - 6.582) < 0.0001
WHR_Z-score 510.3 3.749 (3.343 - 4.205) < 0.0001 360.6 3.123 (2.777 - 3.512) < 0.0001
WHtR_Z-score 694.7 7.188 (6.207 - 8.323) < 0.0001 354.7 5.309 (4.463 - 6.317) < 0.0001
Women (n = 2149)
BRI_Z-score 568.5 5.464 (4.752 - 6.283) < 0.0001 239.9 3.482(2.973 - 4.077) < 0.0001
ABSI_Z-score 117.7 1.648 (1.505 - 1.803) < 0.0001 0.004 1.003 (0.909 - 1.107) 0.9503
WC_Z-score 566.3 6.260 (5.382 - 7.281) < 0.0001 271.9 4.092 (3.461 - 4.838) < 0.0001
BMI_Z-score 511.6 4.307 (3.795 - 4.888) < 0.0001 285.2 3.549(3.064 - 4.111) < 0.0001
WHR_Z-score 360.6 3.123 (2.777 - 3.512) < 0.0001 47.4 1.628 (1.417 - 1.870) < 0.0001
WHtR_Z-score 572.6 5.959 (5.149 - 6.897) < 0.0001 254.4 3.854 (3.265 - 4.549) < 0.0001
Abbreviations: ABSI, a body shape index; BMI, body mass index; BRI, body roundness index; CI, confidence interval; WC, waist circumference; WHR, waist-to-hip ratio;
WHtR, waist-to-height ratio.
Figure 2. The Ability of Obesity Measures in the Diagnosis of NAFLD
ABSI:AUC = O6539
BRI: AUC= 0.8457
WHR: AUC = O.8018
WHtR: AUC = C.8457
ABSI: AUC= 0.6598
BRI: AUC = 0.8566
WHR: AUC = O.7673
WHtR: AUC = C. 8566
Men Women
1
.75
.5
.25
0
1
.75
.5
.25
0
0                     .25                   .5                    .75                     1
False-Positive Rate
0                     .25                   .5                    .75                     1
False-Positive Rate
A B
A is related to men and B is related to women. The blue and red colored curves are related to ABSI and WHR, respectively. The lime color is related to the curves of BRI and
WHtR that completely coincided. ABSI: a body shape index, AUC: area under receiver operating characteristic (ROC) curve, BRI: body roundness index, WHR: waist-to-hip ratio,
WHtR: waist-to-height ratio.
off points of these two indices are interchangeable, using
a simple algebraic equation (a function of BRI in terms of
the variable of WHtR or vice versa).
Our study had some limitations. It had a cross-
sectional design, which is not optimal for establishing
a cause and effect relationship. It is worth mentioning,
though, that since we evaluated the association between
obesity and related indices with NAFLD, determining a
cause and effect relationship is not necessarily logically
problematic. We also did not utilize liver biopsy in the di-
agnosis NAFLD. Applying biopsy (as an invasive diagnos-
tic tool) in a large community based study is not only an
6 Hepat Mon. 2016; 16(9):e39575.
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unethical approach, but also may lead to a relatively high
false-negative rate in the detection of NAFLD (18).
5.1. Conclusion
While BRI and WHtR have an equally strong association
with NAFLD, ABSI and WHR have a weaker association with
NAFLD than BRI and WHtR. The optimal cut-off points of
BRI were 4.00 and 5.00 for men and women, and the op-
timal cut-off points of WHtR were 0.533 and 0.580 for men
and women, respectively.
Supplementary Material
Supplementary material(s) is available here.
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